Burkitt and Burkitt-Like Lymphomas: a Systematic Review

[1]  J. Friedberg,et al.  Burkitt lymphoma- a rare but challenging lymphoma. , 2018, Best practice & research. Clinical haematology.

[2]  R. Bassan,et al.  Burkitt lymphoma in adolescents and young adults: management challenges , 2016, Adolescent health, medicine and therapeutics.

[3]  W. Wilson,et al.  Update on Burkitt Lymphoma. , 2016, Hematology/oncology clinics of North America.

[4]  G. Salles,et al.  Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial , 2016, The Lancet.

[5]  E. Cesarman,et al.  AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma. , 2015, Blood.

[6]  J. Friedberg,et al.  Treating Burkitt Lymphoma in Adults , 2015, Current Hematologic Malignancy Reports.

[7]  E. Thiel,et al.  Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial. , 2014, Blood.

[8]  Lynette M. Smith,et al.  Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow‐positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report , 2014, British journal of haematology.

[9]  L. Staudt,et al.  Low-intensity therapy in adults with Burkitt's lymphoma. , 2013, The New England journal of medicine.

[10]  James R. Anderson,et al.  Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children’s Oncology Group report , 2013, Leukemia.

[11]  S. Montoto,et al.  Autologous and allogeneic transplantation for burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant research. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[12]  C. Harrison,et al.  Burkitt's lymphoma , 2012, The Lancet.

[13]  I. Magrath.  Epidemiology: clues to the pathogenesis of Burkitt lymphoma , 2012, British journal of haematology.

[14]  E. Simard,et al.  AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and/or biology? , 2010, Blood.

[15]  F. Berrino,et al.  Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. , 2010, Blood.

[16]  S. Devesa,et al.  Sporadic childhood Burkitt lymphoma incidence in the United States during 1992–2005 , 2009, Pediatric blood & cancer.

[17]  S. Barrans,et al.  A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial). , 2008, Blood.

[18]  E. Weiderpass,et al.  Burkitt's lymphoma in Africa, a review of the epidemiology and etiology. , 2007, African health sciences.

[19]  S. Perkins,et al.  Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents. , 2007, Blood.

[20]  R. Gascoyne,et al.  Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphoma * , 2006, British journal of haematology.

[21]  Judith A Ferry,et al.  Burkitt's lymphoma: clinicopathologic features and differential diagnosis. , 2006, The oncologist.

[22]  H. Kantarjian,et al.  Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia , 2006, Cancer.

[23]  S. Koscielny,et al.  Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  P. Sonneveld,et al.  Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma , 2005, Leukemia.

[25]  Gerard Lozanski,et al.  Adult Burkitt leukemia and lymphoma. , 2004, Blood.

[26]  A. MacNeil,et al.  Burkitt's lymphoma in Kenya: geographical, age, gender and ethnic distribution. , 2004, East African medical journal.

[27]  O. Martínez-Maza,et al.  B-cell activation and lymphoma in patients with HIV , 2002, Current opinion in oncology.

[28]  M. S. Lewis,et al.  An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[29]  H. Kantarjian,et al.  Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome‐related burkitt lymphoma/leukemia , 2002, Cancer.

[30]  G. Leverger,et al.  The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. , 2001, Blood.

[31]  W. Wilson,et al.  Burkitt's Lymphoma: Molecular Pathogenesis and Treatment , 2000, Cancer investigation.

[32]  M. Tiemann,et al.  Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. , 1999, Blood.

[33]  H. Kantarjian,et al.  Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  F. Berger,et al.  Burkitt-like lymphomas in AIDS patients: characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin's lymphomas. Burkitt's Lymphoma Study Group. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  D. Weisenburger,et al.  New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  R. Hobson,et al.  Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL)--results of the UKCCSG 9003 protocol. , 1998, British Journal of Cancer.

[37]  R. Talamini,et al.  Burkitt's lymphoma in adults with and without human immunodeficiency virus infection , 1998, Cancer.

[38]  D. Knowles.  Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma. , 1996, Hematology/oncology clinics of North America.

[39]  C. Gisselbrecht,et al.  Adult Burkitt's and Burkitt-like non-Hodgkin's lymphoma--outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: results from the European Group for Blood and Marrow Transplantation. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  M. Schrappe,et al.  Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  V. Beral,et al.  AIDS-associated non-Hodgkin lymphoma , 1991, The Lancet.

[42]  C. Pui,et al.  Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  A. Bernard,et al.  Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  S. Schold,et al.  Mental neuropathy from systemic cancer , 1981, Neurology.

[45]  D. Burkitt,et al.  A sarcoma involving the jaws in african children , 1958, CA: a cancer journal for clinicians.

[46]  E. Campo,et al.  The World Health Organization Classification of Lymphoid Neoplasms , 2013 .

[47]  E. Jaffe,et al.  The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. , 2009, Hematology. American Society of Hematology. Education Program.

[48]  S. Pileri,et al.  Bcl-6 protein expression in normal and neoplastic lymphoid tissues. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[49]  J. Zucker,et al.  High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  I. Magrath.  African Burkitt's lymphoma. History, biology, clinical features, and treatment. , 1991, The American journal of pediatric hematology/oncology.

[51]  H. Weinstein,et al.  HiC-COM: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.